Satjit Brar

Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review

Ping Zhao, L Zhang, Joseph A. Grillo et al. · Clinical Pharmacology & Therapeutics · 2010 · 518 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions

Joo Yeon Lee, Christine Garnett, Jogarao Gobburu et al. · Clinical Pharmacokinetics · 2011 · 148 citations

Pharmacy, Pharmaceutical Policy, Pharmacology +9

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

Albert Deisseroth, Edvardas Kaminskas, Joseph A. Grillo et al. · Clinical Cancer Research · 2012 · 147 citations

Medicine, Hematology, Pharmacology +11

Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma

Justin Wilkins, Brigitte Brockhaus, Haiqing Dai et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 74 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17

Changing Body Weight–Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma

Ana Novaković, Justin Wilkins, Haiqing Dai et al. · Clinical Pharmacology & Therapeutics · 2019 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17